BNP Paribas Upgrades Clorox (NYSE:CLX) to “Strong Sell”

BNP Paribas upgraded shares of Clorox (NYSE:CLXFree Report) to a strong sell rating in a research report report published on Friday morning, Zacks.com reports.

A number of other research firms also recently weighed in on CLX. JPMorgan Chase & Co. reduced their target price on shares of Clorox from $150.00 to $148.00 and set a neutral rating for the company in a research report on Friday, August 2nd. DA Davidson reissued a neutral rating and issued a $153.00 target price on shares of Clorox in a research report on Friday. TD Cowen began coverage on Clorox in a research report on Tuesday, July 23rd. They set a sell rating and a $122.00 price target on the stock. Argus raised Clorox to a hold rating in a report on Tuesday, June 4th. Finally, Barclays upped their price objective on shares of Clorox from $122.00 to $130.00 and gave the company an underweight rating in a report on Monday, August 5th. Six investment analysts have rated the stock with a sell rating and thirteen have given a hold rating to the stock. According to MarketBeat, the company presently has an average rating of Hold and an average target price of $143.50.

View Our Latest Report on Clorox

Clorox Stock Performance

Shares of CLX opened at $165.20 on Friday. The stock has a 50 day moving average of $143.55 and a 200 day moving average of $142.87. The company has a current ratio of 1.03, a quick ratio of 0.63 and a debt-to-equity ratio of 5.04. Clorox has a 12 month low of $114.68 and a 12 month high of $166.49. The company has a market capitalization of $20.46 billion, a price-to-earnings ratio of 85.60, a PEG ratio of 3.34 and a beta of 0.40.

Clorox (NYSE:CLXGet Free Report) last released its earnings results on Thursday, August 1st. The company reported $1.82 EPS for the quarter, topping analysts’ consensus estimates of $1.54 by $0.28. The company had revenue of $1.90 billion for the quarter, compared to analysts’ expectations of $1.97 billion. Clorox had a return on equity of 281.12% and a net margin of 3.95%. As a group, sell-side analysts forecast that Clorox will post 6.56 earnings per share for the current year.

Clorox Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Wednesday, August 14th were given a $1.22 dividend. The ex-dividend date of this dividend was Tuesday, August 13th. This is a positive change from Clorox’s previous quarterly dividend of $1.20. This represents a $4.88 annualized dividend and a yield of 2.95%. Clorox’s payout ratio is 252.85%.

Hedge Funds Weigh In On Clorox

A number of large investors have recently modified their holdings of the company. CIBC Private Wealth Group LLC increased its stake in Clorox by 0.5% in the 4th quarter. CIBC Private Wealth Group LLC now owns 13,900 shares of the company’s stock worth $1,982,000 after purchasing an additional 66 shares during the period. Lindbrook Capital LLC grew its holdings in shares of Clorox by 6.2% in the first quarter. Lindbrook Capital LLC now owns 1,182 shares of the company’s stock worth $181,000 after purchasing an additional 69 shares during the last quarter. Fiduciary Group LLC increased its stake in shares of Clorox by 0.4% in the second quarter. Fiduciary Group LLC now owns 19,050 shares of the company’s stock worth $2,600,000 after buying an additional 72 shares during the period. GHP Investment Advisors Inc. raised its holdings in Clorox by 2.0% during the 2nd quarter. GHP Investment Advisors Inc. now owns 3,634 shares of the company’s stock valued at $496,000 after buying an additional 72 shares during the last quarter. Finally, SPC Financial Inc. boosted its position in Clorox by 2.2% during the 2nd quarter. SPC Financial Inc. now owns 3,485 shares of the company’s stock valued at $476,000 after buying an additional 75 shares during the period. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Company Profile

(Get Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Further Reading

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.